Nyxoah SA (NYXH) reports a successful Genio system launch in the US, securing key reimbursements and capital, while navigating cost pressures and early-stage market penetration.

Medicare is launching a significant new prior authorization initiative under the CMS Innovation Center’s Wasteful and Inappropriate Service Reduction (WISeR) model. Beginning January 2026, select ...

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter.

Q3 2025 Earnings Call Transcript November 13, 2025 Nyxoah S.A. misses on earnings expectations. Reported EPS is $-0.74 EPS, ...

REGULATED INFORMATION Nyxoah Reports Third Quarter 2025 Financial and Operating Results US launch off to a strong start. First commercial Genio implants completed with widespread payer coverage drives ...

Nyxoah ( ($NYXH) ) has issued an announcement. On November 13, 2025, Nyxoah announced its unaudited third-quarter results for 2025, highlighting ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range financial plan.

The use of electrical stimulation of the upper airway to treat patients with obstructive sleep apnea (OSA) is supported by low-quality evidence.

Good health and a balanced budget are two key elements of a stress-free retirement, and Medicare is essential to helping you achieve both goals. However, navigating a federal program as complex as ...

Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea “Nearly 2 million ...